Defence Therapeutics Inc.
DTCFF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $70,544 | $25,527 | $25,232 | $40,440 |
| - Cash | $2,080 | $131 | $131 | $57 |
| + Debt | $1,393 | $1,284 | $1,842 | $1,746 |
| Enterprise Value | $69,856 | $26,681 | $26,942 | $42,130 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$851 | -$678 | -$481 | -$1,151 |
| % Margin | – | – | – | – |
| Net Income | -$952 | -$805 | -$607 | -$1,348 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.019 | -0.018 | -0.013 | -0.03 |
| % Growth | -9% | -33.1% | 55.1% | – |
| Operating Cash Flow | -$1,996 | -$668 | $87 | -$532 |
| Capital Expenditures | $0 | $0 | $0 | $17 |
| Free Cash Flow | -$1,996 | -$668 | $87 | -$515 |